CJC-1295 (No DAC) / IPAMORELIN

Price range: $34.95 through $49.99

Description: This research formulation combines CJC-1295 (No DAC) and Ipamorelin in a dual-peptide preparation. CJC-1295 (No DAC), commonly referenced in research as Modified GRF(1-29), is a stabilized growth hormone-releasing hormone (GHRH) analog used to investigate activation of pituitary GHRH receptors (GHRHR) and downstream signaling involved in pulsatile growth hormone (GH) secretion. Ipamorelin is a selective growth hormone secretagogue receptor agonist (GHS-R/GHS-R1a; ghrelin receptor) that stimulates GH release via a complementary secretagogue pathway. Together, the combination is used in research settings to investigate regulation of pulsatile GH secretion, pituitary signaling, and downstream insulin-like growth factor-1 (IGF-1) responses.

Size

Clear

Bundle & Save